Introduction
C. pneumoniae causes approximately 10% of community-acquired pneumonia and 5% of pharyngitis, bronchitis, and sinusitis. The clinical symptoms of C. pneumoniae pulmonary infections are similar to those caused by other respiratory pathogens, except for a few distinguishing features. Antibodies against C. pneumoniae are rare in children under the age of 5, except in developing and tropical countries. Antibody prevalence increases rapidly at ages 5 to 14, reaches 50% at the age of 20, and continues to increase slowly to 70% to 80% at ages 60 to 70. The SeroCP Quant kit is an Enzyme Linked Immunosorbent assay (ELISA) for the semi-quantitative determination of species-specific IgG and IgA antibodies to Chlamydia pneumoniae in human serum.
For In Vitro Diagnostic Use
Features
- Highly purified C. pneumoniae (TWAR-183) elementary bodies as antigens
- Species-specific
- High sensitivity and specificity
- Including a set of 3 calibrators (P10, P50 and P100) allow for semi-quantitative determination of results (as expressed in BU/mL)
SeroCP Quant IgG A291-01
SeroCP Quant IgA A293-01
